Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 31 studies. P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Therapeutics Study Status Closed to Follow Up P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Concluded P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Therapeutics Study Status Concluded P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Concluded P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded P1043/HPTN 040: Neonatal prophylaxis for prevention of IP HIV DAIDS Number 10048 Research Area Other Study Status Concluded P1017: PEG-Intron in HIV+Children DAIDS Number 10317 Research Area Other Study Status Concluded P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Page 2 Current page 3 Page 4 Next page Next
P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis
P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Therapeutics Study Status Closed to Follow Up
P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Concluded
P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Therapeutics Study Status Concluded
P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Concluded
P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded
P1043/HPTN 040: Neonatal prophylaxis for prevention of IP HIV DAIDS Number 10048 Research Area Other Study Status Concluded
P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded
P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded
